BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Freudenberg Medical Invests Over $50 Million in New Hemoteq Production Facility in Germany

Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry with facilities in key industry...

June 12, 2024 | News

Merck Opens Expanded Life Science Distribution Center in Germany

Expands facility by 25,000 square meters, nearly doubling size Adds new down filling capabilities and distribution space for Life Science customers Emp...

June 07, 2024 | News

Thermo Fisher Scientific Opens Cutting-Edge Ultra-Cold Facility in EU to Boost Advanced Therapy Development

Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its c...

June 03, 2024 | News

Thermo Fisher Scientific Announces IVDR Compliance for CytoScan Dx Assay and ChAS Dx Software, Enhancing Cytogenetic Testing in the EU

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied...

May 31, 2024 | News

ProBioGen and ModeX Therapeutics Partner to Accelerate Development of Multi-Specific COVID-19 Antibody

ProBioGen, a leading contract development and manufacturing organization (CDMO), known for its innovative solutions in cell engineering and bioproces...

May 30, 2024 | News

Aptamer Group Signs £465,000 Agreement for Development of Cervical Cancer Blood Test

Agreement for up to £465,000 signed for Optimer development Optimer binders will be developed for use in a cervical cance...

May 22, 2024 | News

Alnylam and Medison Expand Global Partnership to Accelerate Access to Innovative Therapies

The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one glo...

May 01, 2024 | News

Pfizer and Genmab's TIVDAK Wins FDA Full Approval for Cervical Cancer After Outperforming Chemotherapy in Key Trial

TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastat...

April 30, 2024 | News

Aptamer and Kairos Biotech Team Up on Optimer+ for Transplant Rejection Treatments

Partnership will use the new Optimer+ platform Optimer+ EM molecules to be developed to help prevent transplant rejection As part of this agr...

April 19, 2024 | News

Serum Institute of India and Univercells Unite to Make Personalized Cancer Treatments Widely Available

Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells, a Belgian biotech innovator,...

April 12, 2024 | News

Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery

Solutions address shift from animal-based to more human-relevant organoid models, resulting in more accurate predictions in drug discovery Synergies wit...

April 10, 2024 | News

Aptamer Group Files Patent for Cutting-Edge Optimer Binders in Collaboration with Unilever

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, today announces that it has filed a...

April 09, 2024 | News

Bespak Completes Separation from Recipharm,Shifts Focus to Low GWP Inhalers

Bespak announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Gr...

April 02, 2024 | News

South Korean Lunit Forges Ahead in Europe with AI-Enhanced Cancer Detection

Lunit, a trailblazer in AI-driven diagnostics and cancer treatment, announced significant strides in its European market presence through new...

March 19, 2024 | News

Stay Connected